Atlas Trials

Immiseal™ Dural Sealant Post-Market Registry Study

Clinical trial NCT07651826 · RECRUITING

Trial details

NCT number
NCT07651826
Sponsor
Medprin Regenerative Medical Technologies Co., Ltd.
Status
RECRUITING
Study type
OBSERVATIONAL
Dural DefectCerebrospinal Fluid LeakNeurosurgical Procedures
Start date
2026-02-17
Primary completion
2026-08-15
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.